Related Experiment Video
Updated: Sep 26, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV)
Carmen M Ruiz-Jarabo1, Calvin Ly, Esteban Domingo
1Centro de Biologia Molecular Severo Ochoa (CSIC, UAM), Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Abstract:
Passage of the prototypic arenavirus lymphocytic choriomenigitis virus (LCMV) in cultured cells in the presence of the mutagenic agent 5-fluorouracil (FU) resulted in efficient and systematic virus extinction under conditions that did not significantly affect cell survival. FU-mediated extinction of LCMV was associated with 3.6- to 10-fold increases in the mutation frequencies for the three viral genes examined, but with only very modest effects on virus replication and transcription during a single round of infection. Likewise, FU did not affect expression of a LCMV minigenome. In contrast, the well documented antiviral effect of ribavirin against LCMV was not associated with significant increases in virus mutation frequencies, but rather with a dramatic inhibition of both viral RNA synthesis and LCMV minigenome expression. Mutagen induced viral extinction has been recently reported for positive strand RNA viruses polio and foot-and-mouth disease, and the lentivirus HIV-1. Our findings indicate that lethal mutagenesis can be effective also against LCMV, a negative strand RNA virus. Moreover, FU treatment prevented the establishment of LCMV persistent infection in mice deficient in B and T cells, suggesting the feasibility in vivo of lethal mutagenesis as a novel antiviral strategy.
Insights
The antiviral 5-fluorouracil (FU) effectively eliminated lymphocytic choriomenigitis virus (LCMV) by inducing lethal mutagenesis. This novel strategy shows promise for treating LCMV infections in vivo.
Area of Science:
- Virology
- Molecular Biology
- Antiviral Research
Background:
- Lymphocytic choriomenigitis virus (LCMV) is a prototypic arenavirus.
- Existing antiviral strategies may have limitations.
- The potential of lethal mutagenesis as an antiviral approach requires further investigation.
Purpose of the Study:
- To investigate the efficacy of 5-fluorouracil (FU) as a lethal mutagen for eliminating LCMV.
- To compare FU-mediated viral extinction with ribavirin's antiviral mechanism.
- To assess the in vivo feasibility of lethal mutagenesis for LCMV infection.
Main Methods:
- Treatment of cultured cells and mice with FU during LCMV infection.
- Measurement of viral mutation frequencies, replication, and transcription.
- Assessment of LCMV minigenome expression.
- Evaluation of persistent LCMV infection in immunodeficient mice.
Main Results:
- FU treatment led to efficient LCMV extinction in cell culture without significant cell toxicity.
- FU significantly increased mutation frequencies in viral genes, with minimal impact on replication and transcription per cycle.
- Ribavirin inhibited viral RNA synthesis and minigenome expression but did not increase mutation frequencies.
- FU treatment prevented LCMV persistent infection in vivo in B and T cell-deficient mice.
Conclusions:
- Lethal mutagenesis using FU is an effective strategy against LCMV, a negative-strand RNA virus.
- This approach differs mechanistically from ribavirin's antiviral action.
- In vivo prevention of persistent LCMV infection suggests the potential of lethal mutagenesis as a novel antiviral therapy.
Related Concept Videos
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cytomegalovirus Disease

